{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:55:01Z","timestamp":1781729701269,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-230x-12-121","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T10:14:39Z","timestamp":1346840079000},"source":"Crossref","is-referenced-by-count":14,"title":["Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study"],"prefix":"10.1186","volume":"12","author":[{"given":"Daniel","family":"Keszthelyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen H","family":"Dackus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen M","family":"Masclee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna W","family":"Kruimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad AM","family":"Masclee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"issue":"6","key":"785_CR1","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology. 2002, 123 (6): 2108-2131. 10.1053\/gast.2002.37095.","journal-title":"Gastroenterology"},{"issue":"7","key":"785_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2165\/00019053-200220070-00003","volume":"20","author":"RL Akehurst","year":"2002","unstructured":"Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M, Walters SJ: Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics. 2002, 20 (7): 455-462. 10.2165\/00019053-200220070-00003.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"785_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s10620-009-0765-9","volume":"55","author":"AP Kerckhoffs","year":"2010","unstructured":"Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W: Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010, 55 (3): 716-723. 10.1007\/s10620-009-0765-9.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"785_CR4","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1111\/j.1572-0241.2008.01992.x","volume":"103","author":"BM Spiegel","year":"2008","unstructured":"Spiegel BM, Chey WD, Chang L: Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?. Am J Gastroenterol. 2008, 103 (12): 2972-2976. 10.1111\/j.1572-0241.2008.01992.x.","journal-title":"Am J Gastroenterol"},{"key":"785_CR5","volume-title":"Facts and figures 2009","author":"Stichting Farmaceutische Kerngetallen (SKF)","year":"2010","unstructured":"Stichting Farmaceutische Kerngetallen (SKF): Facts and figures 2009. 2010, Available from: \n                    http:\/\/www.sfk.nl\/pdf-documenten\/data-en-feiten\/data-en-feiten-2009\n                    \n                  , accessed 15 August,"},{"issue":"7634","key":"785_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A: Overprescribing proton pump inhibitors. BMJ. 2008, 336 (7634): 2-3. 10.1136\/bmj.39406.449456.BE.","journal-title":"BMJ"},{"issue":"5","key":"785_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2036.2008.03900.x","volume":"29","author":"OS van Boxel","year":"2009","unstructured":"van Boxel OS, Hagenaars MP, Smout AJ, Siersema PD: Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther. 2009, 29 (5): 571-579. 10.1111\/j.1365-2036.2008.03900.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"785_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.997","volume":"13","author":"WG Goettsch","year":"2004","unstructured":"Goettsch WG, van den Boom G, Breekveldt-Postma NS, Smout AJ, Herings RM: Treatment patterns and health care costs of mebeverine-treated IBS patients: a case\u2013control study. Pharmacoepidemiol Drug Saf. 2004, 13 (11): 803-810. 10.1002\/pds.997.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"785_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1365-2036.2010.04453.x","volume":"32","author":"D Keszthelyi","year":"2010","unstructured":"Keszthelyi D, Jansen SV, Schouten GA, de Kort S, Scholtes B, Engels LG, Masclee AA: Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case\u2013control study. Aliment Pharmacol Ther. 2010, 32 (9): 1124-1128. 10.1111\/j.1365-2036.2010.04453.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"785_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ibd.20059","volume":"13","author":"D Limsui","year":"2007","unstructured":"Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007, 13 (2): 175-181. 10.1002\/ibd.20059.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"785_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/gast.2002.34784","volume":"123","author":"N Burgel","year":"2002","unstructured":"Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD: Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 2002, 123 (2): 433-443. 10.1053\/gast.2002.34784.","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"785_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1365-2036.2008.03824.x","volume":"28","author":"JM Mullin","year":"2008","unstructured":"Mullin JM, Valenzano MC, Whitby M, Lurie D, Schmidt JD, Jain V, Tully O, Kearney K, Lazowick D, Mercogliano G, et al: Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther. 2008, 28 (11\u201312): 1317-1325.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"785_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","volume":"8","author":"L Lombardo","year":"2010","unstructured":"Lombardo L, Foti M, Ruggia O, Chiecchio A: Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010, 8 (6): 504-508. 10.1016\/j.cgh.2009.12.022.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"785_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3945\/jn.110.135657","volume":"141","author":"D Ulluwishewa","year":"2011","unstructured":"Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC: Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011, 141 (5): 769-776. 10.3945\/jn.110.135657.","journal-title":"J Nutr"},{"issue":"11","key":"785_CR15","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003, 98 (11): 2454-2459. 10.1111\/j.1572-0241.2003.07699.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"785_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cgh.2009.07.020","volume":"8","author":"AC Ford","year":"2010","unstructured":"Ford AC, Marwaha A, Lim A, Moayyedi P: Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010, 8 (5): 401-409. 10.1016\/j.cgh.2009.07.020.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"785_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1572-0241.2000.01678.x","volume":"95","author":"GR Locke 3rd","year":"2000","unstructured":"Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ: Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol. 2000, 95 (1): 157-165. 10.1111\/j.1572-0241.2000.01678.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"785_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.aje.a117548","volume":"142","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, Zinsmeister AR, Melton LJ: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995, 142 (1): 76-83.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"785_CR19","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/0016-5085(95)90708-4","volume":"108","author":"I Bjarnason","year":"1995","unstructured":"Bjarnason I, MacPherson A, Hollander D: Intestinal permeability: an overview. Gastroenterology. 1995, 108 (5): 1566-1581. 10.1016\/0016-5085(95)90708-4.","journal-title":"Gastroenterology"},{"issue":"11","key":"785_CR20","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1046\/j.1365-2036.2003.01591.x","volume":"17","author":"JS Kalantar","year":"2003","unstructured":"Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ: Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003, 17 (11): 1389-1397. 10.1046\/j.1365-2036.2003.01591.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"785_CR21","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason I, Hayllar J, MacPherson AJ, Russell AS: Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993, 104 (6): 1832-1847.","journal-title":"Gastroenterology"},{"issue":"5","key":"785_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I: A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005, 128 (5): 1172-1178. 10.1053\/j.gastro.2005.03.020.","journal-title":"Gastroenterology"},{"issue":"6","key":"785_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1365-2362.2010.02290.x","volume":"40","author":"S Fujimori","year":"2010","unstructured":"Fujimori S, Gudis K, Takahashi Y, Seo T, Yamada Y, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, et al: Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest. 2010, 40 (6): 504-510. 10.1111\/j.1365-2362.2010.02290.x.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"785_CR24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","volume":"141","author":"JL Wallace","year":"2011","unstructured":"Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, Jury J, Bolla M, Bercik P, Collins SM, et al: Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011, 141 (4): 1314-1322. 10.1053\/j.gastro.2011.06.075. 1322 e1311-1315","journal-title":"Gastroenterology"},{"issue":"4","key":"785_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1046\/j.1365-2036.1996.d01-506.x","volume":"10","author":"SJ Lewis","year":"1996","unstructured":"Lewis SJ, Franco S, Young G, O'Keefe SJ: Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996, 10 (4): 557-561. 10.1046\/j.1365-2036.1996.d01-506.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"785_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.02707.x","volume":"23","author":"C Williams","year":"2006","unstructured":"Williams C, McColl KE: Review article: proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther. 2006, 23 (1): 3-10. 10.1111\/j.1365-2036.2006.02707.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"785_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/gut.39.1.54","volume":"39","author":"J Thorens","year":"1996","unstructured":"Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, et al: Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996, 39 (1): 54-59. 10.1136\/gut.39.1.54.","journal-title":"Gut"},{"issue":"1","key":"785_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/gut.35.1.23","volume":"35","author":"M Fried","year":"1994","unstructured":"Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, Blum A, Bille J, Gonvers JJ, Gyr K: Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994, 35 (1): 23-26. 10.1136\/gut.35.1.23.","journal-title":"Gut"},{"issue":"6","key":"785_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cgh.2011.02.030","volume":"9","author":"BM Spiegel","year":"2011","unstructured":"Spiegel BM: Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011, 9 (6): 461-469. 10.1016\/j.cgh.2011.02.030. quiz e459","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"785_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","volume":"33","author":"RS Choung","year":"2011","unstructured":"Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA: Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011, 33 (9): 1059-1067. 10.1111\/j.1365-2036.2011.04625.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"785_CR31","doi-asserted-by":"crossref","unstructured":"Keszthelyi D, Masclee AA: Effects of proton pump inhibitor therapy in the distal gut: putting the pieces together. Dig Dis Sci. 10.1007\/s10620-012-2339-5. Epub 17 Aug 2012","DOI":"10.1007\/s10620-012-2339-5"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-121\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T08:34:22Z","timestamp":1548146062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-121","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,5]]},"article-number":"121"}}